Stocks Pfizer Inc

More

  • Big pharma lobbyists for Pfizer couldn't save the Allergan merger deal, is the lobbying bubble bursting before our eyes?

  • narcissist

    New research suggests that CEO narcissism affects a company's use of tax shelters like the corporate inversions now under fire from the Treasury.

  • The war on business

    Discussing making America more competitive, as well as the presidential candidates, with Former Medtronic CEO Bill George and Wilbur Ross, WL Ross & Co. Chairman and CEO.

  • Hassan: Pfizer is a bigger story than just taxes

    Fred Hassan, Warburg Pincus Managing Director and CNBC Contributor, talks about tax inversions in the pharmaceutical industry and his advice to Pfizer after its deal with Allergan fell through.

  • Pfizer headquarters in New York.

    If 2015 was a dream year for Wall Street's top dealmakers, 2016 is starting to take a nightmarish turn.

  • Pfizer

    The inversion clampdown makes it more difficult for companies to stay competitive, says Sanford Bernstein's Ronny Gal.

  • Pfizer

    Pfizer is worth a lot more than it is trading at, based on the potential for future spin-offs, explains Bill Smead of Smead Capital Management.

  • The "Fast Money" traders reveal their final trades of the day.

  • Pennsylvania Avenue at dusk, Washington D.C.

    As the U.S. government looks to curb tax inversions these experts discuss the implications of new laws.

  • Allergan in the NYSE

    Jim Cramer says the bulls should be thanking the Treasury & Justice departments, even if they accidentally sparked a rally.

  • Kenneth Frazier, CEO of Merck.

    Merck CEO Kenneth Frazier said a flawed corporate tax system drives inversion deals that have drawn the government's ire.

  • Cramer: Thank the Treasury for accidental rally

    Jim Cramer says the bulls should be thanking the Treasury & Justice departments, as they accidentally sparked a rally in these stocks.

  • Final Trades: AGN, EWA, PFE & DRI

    The "Fast Money" traders share their final trades of the day.

  • The Allergan 'Dating Game'

    The "Fast Money" traders play "The Dating Game" for Allergan's potential new partner now that that its deal with Pfizer is off the table.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher Wednesday, led by gains in health care and energy, after the release of the Fed meeting minutes.

  • Is the government targeting M&A?

    Discussing how moves like the Treasury's new tax inversion rules could affect mergers and acquisitions going forward with Martin Okner, SHM Corporate Navigators Managing Partner, and Nicholas Fortuna, Partner at Allyn & Fortuna

  • A logo sits on the lab coat of a technician as he works at Neusentis Ltd.'s research laboratory, a unit of Pfizer Inc.

    The Pfizer, Allergan merger effort has reignited a debate over corporate inversions, says Yevgeniy Feyman. But US jobs are not really at stake.

  • America's 'hot mess' tax code

    CNBC contributors Jared Bernstein and James Pethokoukis react to the regulatory change by the Treasury on taxes.

  • Traders buy into Allergan

    The Allergan-Pfizer deal has been terminated after the Treasury tightened tax rules, with the FMHR traders.

  • Offshore oil rig

    European markets finished higher Wednesday as investors digested new data out of China, while eyeing the latest moves in the oil price.